» Articles » PMID: 38698239

The Ouroboros of Autoimmunity

Overview
Journal Nat Immunol
Date 2024 May 2
PMID 38698239
Authors
Affiliations
Soon will be listed here.
Abstract

Human autoimmunity against elements conferring protective immunity can be symbolized by the 'ouroboros', a snake eating its own tail. Underlying infection is autoimmunity against three immunological targets: neutrophils, complement and cytokines. Autoantibodies against neutrophils can cause peripheral neutropenia underlying mild pyogenic bacterial infections. The pathogenic contribution of autoantibodies against molecules of the complement system is often unclear, but autoantibodies specific for C3 convertase can enhance its activity, lowering complement levels and underlying severe bacterial infections. Autoantibodies neutralizing granulocyte-macrophage colony-stimulating factor impair alveolar macrophages, thereby underlying pulmonary proteinosis and airborne infections, type I interferon viral diseases, type II interferon intra-macrophagic infections, interleukin-6 pyogenic bacterial diseases and interleukin-17A/F mucocutaneous candidiasis. Each of these five cytokine autoantibodies underlies a specific range of infectious diseases, phenocopying infections that occur in patients with the corresponding inborn errors. In this Review, we analyze this ouroboros of immunity against immunity and posit that it should be considered as a factor in patients with unexplained infection.

Citing Articles

Genetic diversity of the immunoglobulin heavy chain locus in cohorts of patients affected with SARS-CoV-2.

Malaspina P, Jodice C, Ciminelli B, Biancolella M, Colona V, Latini A Hum Genomics. 2025; 19(1):7.

PMID: 39885568 PMC: 11780896. DOI: 10.1186/s40246-025-00719-8.


The monogenic landscape of human infectious diseases.

Boisson-Dupuis S, Bastard P, Beziat V, Bustamante J, Cobat A, Jouanguy E J Allergy Clin Immunol. 2024; 155(3):768-783.

PMID: 39724971 PMC: 11875930. DOI: 10.1016/j.jaci.2024.12.1078.


A common form of dominant human IFNAR1 deficiency impairs IFN-α and -ω but not IFN-β-dependent immunity.

Al Qureshah F, Le Pen J, de Weerd N, Moncada-Velez M, Materna M, Lin D J Exp Med. 2024; 222(2).

PMID: 39680367 PMC: 11648951. DOI: 10.1084/jem.20241413.


A Novel Heterozygous NFKB2 Variant in a Multiplex Family with Common Variable Immune Deficiency and Autoantibodies Against Type I IFNs.

Baran A, Atilgan Lulecioglu A, Gao L, Yazici Y, Demirel F, Metin A J Clin Immunol. 2024; 45(1):48.

PMID: 39579251 PMC: 11821294. DOI: 10.1007/s10875-024-01843-1.


Genetic defects of brain immunity in childhood herpes simplex encephalitis.

Zhang S, Casanova J Nature. 2024; 635(8039):563-573.

PMID: 39567785 PMC: 11822754. DOI: 10.1038/s41586-024-08119-z.


References
1.
Liblau R, Wong F, Mars L, Santamaria P . Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention. Immunity. 2002; 17(1):1-6. DOI: 10.1016/s1074-7613(02)00338-2. View

2.
Sciascia S, Bizzaro N, Meroni P, Dimitrios B, Borghi M, Bossuyt X . Autoantibodies testing in autoimmunity: Diagnostic, prognostic and classification value. Autoimmun Rev. 2023; 22(7):103356. DOI: 10.1016/j.autrev.2023.103356. View

3.
Wang L, Wang F, Gershwin M . Human autoimmune diseases: a comprehensive update. J Intern Med. 2015; 278(4):369-95. DOI: 10.1111/joim.12395. View

4.
Price J, Haddon D, Kemmer D, Delepine G, Mandelbaum G, Jarrell J . Protein microarray analysis reveals BAFF-binding autoantibodies in systemic lupus erythematosus. J Clin Invest. 2013; 123(12):5135-45. PMC: 3859403. DOI: 10.1172/JCI70231. View

5.
Ilonen J, Lempainen J, Veijola R . The heterogeneous pathogenesis of type 1 diabetes mellitus. Nat Rev Endocrinol. 2019; 15(11):635-650. DOI: 10.1038/s41574-019-0254-y. View